1-800 Contacts Sold to WellPoint for $900 Million



1-800 Contacts Sold to WellPoint for $900 Million

WellPoint, Inc. (NYSE:WLP), one of the largest health insurers in America is acquiring the eyewear retailer 1-800 Contacts, Inc. for close to $900 million.  The seller is private equity firm Fenway Partners Inc, according to a Wall Street Journal report.

Pros And Cons Of Tail Risk Funds

tail risk fundsEditor’s note: This article is part of a series ValueWalk is doing on tail risk hedge funds. The series is based on over a month of research and discussions with over a dozen experts in the field. All the content will be first available to our premium subscribers and some will be released at a Read More

The deal is likely to be closed in the third quarter and will be financed with cash on hand. “We see a unique way of tying 1-800 Contacts into our product design,” WellPoint Chief Financial Officer Wayne DeVeydt said. “WellPoint would also get a diversified revenue stream into a higher-margin business,” he further added.

The post-tax margin rates are in double digit range for 1-800 Contacts as compared to 4-5% of WellPoint’s health insurance business. 1-800 sells prescription contact lenses over the phone and online. After the acquisition WellPoint will directly sell vision services to the customers.

Fenway Partners, Inc. had acquired 1-800 Contacts for $340 million in June 2007 and after five years it’s getting $900 million. WellPoint is making a string of investments to form a strong bond with its customers. 1-800 will compliment the vision insurance business of WellPoint which has over 4.2 million customers. The company hopes to capitalize on a shift towards people selecting their own health coverage and healthcare products.

It’s not just WellPoint, Inc. (NYSE:WLP), but many other health insurers are diversifying their businesses to build more direct contact with customers. Cigna Corp. is running new marketing campaigns to improve direct-to-customer business, United Health Group entered the hearing-aid business with plans to sell the devices directly to customers over the Internet, Humana Inc. (NYSE:HUM) has entered into partnership with Wal-Mart Stores to sell a Medicare drug plan.